INC Research, LLC Third Quarter 2011 Results of Operations Release Date and Conference Call

INC Research, LLC Third Quarter 2011 Results of Operations Release Date and Conference Call

ID: 83169

(Thomson Reuters ONE) -


Raleigh, NC, Nov. 2, 2011 - INC Research, LLC, a therapeutically focused
clinical research organization (CRO) with a Trusted Process(®) for delivering
reliable results, will conduct a conference call to discuss its third quarter
financial results at 10 a.m. ET on Tuesday, Nov. 29, 2011.  The third quarter
financial results also will be available on the Company's secure website at the
opening of business on Monday, Nov. 28, 2011.

To access the financial results and dial-in information for the conference call,
a party must pre-register and certify that it is eligible to do so.  Access to
the financial results and conference call will be available only to (1) holders
of the Company's 11.5% Senior Notes due 2019, (2) hi-yield securities analysts
and broker-dealers and (3) prospective investors that certify that they are
qualified institutional buyers as defined in Rule 144A under the Securities Act
of 1933, as amended.  To receive information on how to pre-register and certify
eligibility, parties must send an email to wlumpkin(at)incresearch.com requesting
access to the financial results and conference call information no later than
Nov. 28, 2011.

About INC Research, LLC
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development programs
of the highest integrity.  Pharmaceutical and biotechnology companies look to
INC Research for a complete range of customized Phase I through Phase IV
programs in all therapeutic areas and innovative pediatric and women's health
trials.  The company's Trusted Process(®) methodology and therapeutic foresight
lead customers to more confident, better-informed drug and device development
decisions.  INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com.





Contacts:
INC Research, LLC
Willis Lumpkin, Treasurer, 919-341-3230
David Gill, CFO, 919-745-2716






This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: INC RESEARCH, LLC via Thomson Reuters ONE

[HUG#1560193]


Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Prosafe SE: Dividend approved Information regarding Active Biotech's candidate drug laquinimod
Bereitgestellt von Benutzer: hugin
Datum: 02.11.2011 - 14:34 Uhr
Sprache: Deutsch
News-ID 83169
Anzahl Zeichen: 2713

contact information:
Town:

Raleigh



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 138 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"INC Research, LLC Third Quarter 2011 Results of Operations Release Date and Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von

INC RESEARCH, LLC (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von INC RESEARCH, LLC



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z